Please ensure Javascript is enabled for purposes of website accessibility
Home > Products > Antibodies > Primary antibodies

Anti-ZEBOV VP35/Polymerase cofactor VP35 Recombinant Antibody (F9) (VK661013)

Anti-ZEBOV VP35/Polymerase cofactor VP35 Recombinant Antibody (F9)
Anti-ZEBOV VP35/Polymerase cofactor VP35 Recombinant Antibody (F9)
Price(USD): --
Spec:
  • 50ug
  • 100ug
  • 1mg
Number:
Get quote
  • Overview

  • Images

  • References

  • Datasheet

  • SDS

Overview
Catalog No.VK661013
Description
Anti-ZEBOV VP35/Polymerase cofactor VP35 Recombinant Antibody (F9) (VK661013) is a human monoclonal antibody detecting VP35/Polymerase cofactor VP35 in ELISA, WB. Suitable for Zaire ebolavirus (ZEBOV) (Zaire Ebola virus).
Highlights
  • ●Affinity Purified — Minimal background and high purity for reliable results.
  • ●Multi-Application — Validated across multiple applications.
Species reactivityZaire ebolavirus (ZEBOV) (Zaire Ebola virus)
ApplicationsELISA, WB
Host speciesHuman
ClonalityMonoclonal
IsotypeIgG
Clone IDF9
Target VP35, Polymerase cofactor VP35, Ebola VP35, eVP35
Endotoxin level < 10 EU/mg as determined by LAL method.
Purity >95% as determined by SDS-PAGE.
Purification Protein A/G purified from cell culture supernatant.
Accession Q05127
RRID Anti-ZEBOV VP35/Polymerase cofactor VP35 Antibody (F9) (abinScience Cat# VK661013, RRID:AB_3727248)
Form Liquid
Storage buffer 0.01M PBS pH 7.4

Please refer to the specific buffer information in the hardcopy of datasheet or the lot-specific COA.

Product Usage Information
Application Dilution
ELISA 1:2000-1:20000
WB 1:500-1:2000
Stability and Storage Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.
Background

Polymerase cofactor VP35 is a ~37 kDa protein. Plays an essential role in viral RNA synthesis and also a role in suppressing innate immune signaling. Acts as a polymerase cofactor in the RNA polymerase transcription and replication complexes. Serves as nucleoprotein/NP monomer chaperone prior to the formation of the large oligomeric RNA-bound complexes. Part of the external layer of the nucleocapsid, likely tethering the nucleocapsid to the matrix and membrane. Regulates RNA synthesis by modulating NP-RNA interactions and interacting with DYNLL1.

1. Basler, CF. et al. (2000) Proceedings of the National Academy of Sciences of the United States of America 97, 12289-94. PMID: 11027311
2. van Tol, S. et al. (2022) PLoS pathogens 18, e1010532. PMID: 35533195
3. Enterlein, S. et al. (2006) Antimicrobial agents and chemotherapy 50, 984-93. PMID: 16495261
4. Brown, CS. et al. (2014) Journal of molecular biology 426, 2045-58. PMID: 24495995
5. Mühlberger, E. et al. (1999) Journal of virology 73, 2333-42. PMID: 9971816
6. Watanabe, R. et al. (2024) Cell 187, 5587-5603.e19. PMID: 39293445
7. Luthra, P. et al. (2015) Journal of virology 89, 5148-53. PMID: 25741013
8. Leung, DW. et al. (2015) Cell reports 11, 376-89. PMID: 25865894
9. Yen, BC. et al. (2016) Journal of virology 90, 5108-5118. PMID: 26962215
10. Luthra, P. et al. (2013) Cell host & microbe 14, 74-84. PMID: 23870315
Note For research use only.
Images
  • Anti-ZEBOV VP35/Polymerase cofactor VP35 Recombinant Antibody (F9)

    SDS-PAGE

    SDS-PAGE for Anti-ZEBOV VP35/Polymerase cofactor VP35 Antibody (F9)

References
Formula
Mass (g) = Concentration (mol/L) × Volume (L) × MW (g/mol)
Enter any 2 of Mass, Concentration, Volume + Molecular Weight to solve for the unknown.
Mass
=
Concentration
×
Volume
Molecular Weight *
g/mol
Formula
C₁ × V₁ = C₂ × V₂
Enter any 3 of the 4 values to solve for the unknown.
Stock Solution
C₁ (Stock Conc.)
×
V₁ (Stock Vol.)
=
Working Solution
C₂ (Working Conc.)
×
V₂ (Working Vol.)
Recommendation

Contact us for custom quotes, bulk requests and any other issues.

Mail: [email protected]

Distributor list